Pro-urokinase a Less Expensive Thrombolytic for Stroke

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Recombinant human pro-urokinase was non-inferior to alteplase in achieving an excellent functional outcome in patients with acute ischemic stroke but had a lower ICH rate.
Medscape Medical News